| Nusinersen in the treatment of spinal muscular atrophy K Goodkey, T Aslesh, R Maruyama, T Yokota Exon skipping and inclusion therapies: Methods and protocols, 69-76, 2018 | 50 | 2018 |
| Regulation of CNS precursor function by neuronal chemokines AES Watson, K Goodkey, T Footz, A Voronova Neuroscience letters 715, 134533, 2020 | 44 | 2020 |
| Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model MMA de Almeida, AES Watson, S Bibi, NL Dittmann, K Goodkey, ... Stem Cell Reports 18 (2), 519-533, 2023 | 13 | 2023 |
| Regulation of microglia function by neural stem cells MMA de Almeida, K Goodkey, A Voronova Frontiers in Cellular Neuroscience 17, 1130205, 2023 | 6 | 2023 |
| Ankrd11, a chromatin regulator and a KBG syndrome risk gene, is a critical regulator of cardiac neural crest cell biology and heart development Y Kibalnyk, R Noble, M Alexiou, I Poverennaya, N Dittmann, A Greenwell, ... | 3 | 2023 |
| Olfactory bulb anomalies in KBG syndrome mouse model and patients K Goodkey, A Wischmeijer, L Perrin, AES Watson, L Qureshi, DM Cordelli, ... BMC medicine 22 (1), 158, 2024 | | 2024 |
| Investigating fractalkine as a potential remyelination therapy in the cuprizone ms mouse model MM De Almeida, A Watson, F Khan, J Li, K Goodkey, T Footz, ... MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 70-70, 2020 | | 2020 |
